MINNEAPOLIS, Feb. 4, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Amy E. Herr, Ph.D. to serve as an independent director on the Company's Board of ...

The completion of Dr. Herr's appointment marks the end of a two-year search by Bio-Techne's Board of Directors for successors to retiring members. Kim Kelderman, President and CEO of Bio-Techne ...

Jan. 28, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced the appointment of Kevin Finney to the Company’s Board of Directors ... and terms of similar ...

SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell ...

Corporation (NASDAQ: TECH), a global life sciences company valued at $11.45 billion, has announced the appointment of Dr. Amy E. Herr as an independent director on its Board of Directors. Dr. Herr ...

“Dan is a pharmaceutical industry veteran who brings decades of leadership experience in clinical and regulatory strategy to our Board of Directors. Importantly, he has invaluable experience in the ...

Frissora’s distinguished career and proven ability to drive industry-leading transformations make his addition to the board a significant milestone in BioAdaptives’ journey. The company is ...

LAS VEGAS, Feb. 03, 2025 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC: BDPT), a pioneering health and wellness company dedicated to innovative, science-driven solutions, is proud to announce the ...

Detailed price information for Windtree Therapeutics Inc (WINT-Q) from The Globe and Mail including charting and trades.

Introducing our new series of great engagement opportunities, a monthly Leaders Forum at Greenhouse, Salesforce Tower, Sydney ...